Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 36: 119-123, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lensmeyer, G. L.
Right arrow Articles by deVos, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lensmeyer, G. L.
Right arrow Articles by deVos, D. J.

Clinical Chemistry, Vol 36, 119-123, Copyright © 1990 by American Association for Clinical Chemistry

Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites

GL Lensmeyer, DA Wiebe, IH Carlson and DJ deVos
Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital & Clinics, Madison 53792.

We demonstrate the diverse selectivity of three commercial polyclonal "cyclosporine" immunoassays for cyclosporin (CsA) metabolites by comparing analytical responses of nine metabolites added to drug-free whole-blood specimens (range 0 to 2000 micrograms/L) and assayed by the Abbott TDx fluorescence polarization immunoassay (FPIA), the Incstar Cyclo-Trac radioimmunoassay (RIA), and the Sandoz RIA. Cross-reactivity- -defined as the relative response (slope of regression line) of metabolite/parent CsA over the assay's linear range of concentrations-- differed for each metabolite among the three assays. Overall, Abbott's antiserum exhibited the greatest affinity for the metabolites, the Sandoz antiserum the least. Ranges of cross-reactivity for the metabolites over all three assays were M1 (14-44%), M8 (9-20%), M13 (13- 26%), M17 (50-116%), M18 (17-79%), M21 (4-54%), M25 (less than 1-52%), M26 (less than 1-29%), and M203-218 (7-51%). The specificities of the Abbott, Incstar, and Sandoz polyclonal assays thus differ significantly, and this brings into question the practical utility of comparing data generated for patients' specimens by different procedures.


The following articles in journals at HighWire Press have cited this article:


Home page
 Nephrol Dial TransplantHome page
J. Waiser, T. Slowinski, A. Brinker-Paschke, K. Budde, M. Schreiber, T. Bohler, I. Hauser, and H.-H. Neumayer
Impact of the variability of cyclosporin A trough levels on long-term renal allograft function
Nephrol. Dial. Transplant., July 1, 2002; 17(7): 1310 - 1317.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.